JPMC to introduce preimplantation genetic screening
A PROCEDURE to boost the success rate of healthy conception through In-Vitro Fertilisation (IVF) will be available in Brunei this July, following the signing of an agreement yesterday between Jerudong Park Medical Centre (JPMC) with research and diagnostics firm Sengenics Sdn Bhd.
JPMC Executive Director and Medical Director Dato Paduka Dr Hj Mohd Isham Hj Jaafar said the procedure called preimplantation genetic screening (PGS) will increase the success rate of IVF treatment from 30 to 90 per cent.
Head of Obstetrics, Gynaecology and Reproductive Medicine Unit Dr Chitra Karat said PGS is an IVF procedure designed to examine embryos for chromosomal abnormalities.
The fertility expert said while PGS does not improve the quality of IVF embryos, it gives specialists a new way to identify the healthiest embryos.
“It (the procedure) is diagnostic, so with that we will be able to say whether a particular embryo is normal or not. If it is a normal embryo, the chance of getting pregnant is very high,” she told The Brunei Times.
Dr Karat said one of the benefits of PGS is the prevention of certain diseases or disorders from being passed on to the child.
“First, one or two cells are removed from the embryo, the cells are then evaluated to determine if the inheritance of a problematic gene is present in the embryo. Once the PGS procedure has been performed and embryos free of genetic problems have been identified, the embryo will be placed back in the uterus, and implantation will be attempted,” she explained.
Dr Karat added that JPMC is the only institute in Brunei offering all types of treatment for infertility, starting from ovulation induction, intrauterine insemination (IUI) and IVF, noting that there is a growing need for IVF treatment in Brunei.
According to JPMC spokeperson Aini Asbinin, IVF treatments could cost from $8000 to $20,000, depending on the patient’s case.
Present to sign the MoU on behalf of JPMC was Abdul Latiff Pehin Orang Kaya Seri Setia Dato Paduka Hj Md Yusuf, a member of Board of Directors of JPMC, while Sengenics was represented by Sengenics Commercial Director Johan Poole-Johnson.
Poole-Johnson told reporters that Sengenics is pleased to partner with JPMC and believes Brunei has the potential to become a medical tourism hub.
Sengenics Executive Director Dr Arif Anwar said he hopes the partnership will strengthen Brunei’s global reputation in the medical tourism sector.
He added that they are currently trying to partner with Royal Brunei (RB) airlines and The Empire Hotel and Country Club to try to draw more international clients into the country.
The Brunei Times